Nebiye YENTUR, İsa AN, Erhan AYHAN, Murat ÖZTÜRK, Mustafa AKSOY, Naime EROĞLU

Clinical features of patients diagnosed with recidivan cutaneous leishmaniasis

Aim: Cutaneous leishmaniasis (CL) is a disease with chronic nodulo-ulcerative lesions on the skin that heals with atrophic scars.This study aims to investigate the clinical features of patients admitted to our clinic and diagnosed as recidivan CL.Material and Methods: This retrospective study included 11 patients who were admitted to our skin and venereal diseases clinicbetween October 2017 and July 2019 and who were diagnosed as recidivan CL by anamnesis, clinical and microscopic examination.Clinical characteristics of the patients such as age, sex, survival in the endemic region, intralesional or systemic antimony therapyand number, location, size and duration of the lesions were recorded.Results: Seven (63.6%) of the 11 patients were male and 4 (36.4%) were female. The mean age of the patients was 13.8 ± 4.04 years.All of the patients in the study had one lesion on their face. The mean lesion duration was 36.27 ± 24.3 months. The mean lesionsize was 6.9 ± 3.4 cm. Before the diagnosis, 2 (18.2%) patients received intralesional antimony treatment, 1 patient (9.1%) receivedsystemic antimony treatment, and 8 (72.7%) patients did not receive any treatment.Conclusion: In conclusion, recidivan CL is a rare form of chronic CL. Because parasites are rare in the lesions, the diagnosis is usuallydelayed and therefore the lesions can cause destruction and deformity. Prospective studies with a large number of patients areneeded to better understand the clinical findings of recidivan CL.

PDF

___

1. An I, Harman M, Esen M, et al. The effect of pentavalent antimonial compounds used in the treatment of cutaneous leishmaniasis on hemogram and biochemical parameters. Cutan Ocul Toxicol 2019;38:294-7.
2. Aksoy M, Yesilova A, Yesilova Y, et al. Determination factors of affecting the risks of non-recovery in cutaneous leishmaniasis patients using binary logistic regression. Ann Med Res 2018;25:530-5.
3. An I, Harman M, Cavus I, et al. The Diagnostic Value of Lesional Skin Smears Performed by Experienced Specialist in Cutaneous Leishmaniasis and Routine Microbiology Laboratory. Turk J Dermatol 2019;13:1-5.
4. Harman M. Cutaneous leishmaniasis. Turk J Dermatol 2015;9:168-76.
5. Eroglu N, An I, Aksoy M. Dermoscopic features of cutaneous leishmaniasis lesions. Turk J Dermatol 2019;13:103-8.
6. Gurel MS, Ulukanligil M, Ozbilge H. Cutaneous leishmaniasis in Sanliurfa:epidemiologic and clinical features of the last four years (1997-2000). Int J Dermatol 2002;41:32-7.
7. Momeni AZ, Aminjavaheri M. Clinical picture of cutaneous leishmaniasis in Isfahan, Iran. Int J Dermatol 1994;33:260-5.
8. Uzun S, Uslular C, Yucel A, et al. Cutaneous leishmaniasis: evaluation of 3,074 cases in the Cukurova region of Turkey. Br J Dermatol 1999;140:347-50.
9. Douba MD, Abbas O, Wali A, et al. Chronic cutaneous leishmaniasis, a great mimicker with various clinical presentations: 12 years experience from Aleppo. J Eur Acad Dermatol Venereol. 2012;26:1224-9.
10. Bailey MS, Lockwood DN. Cutaneous leishmaniasis. Clin Dermatol. 2007;25:203-11.
11. Ok UZ, Balcioğlu IC, Taylan Ozkan A, et al. Leishmaniasis in Turkey. Acta Trop. 2002;84:43-8.
12. Hepburn NC. Cutaneous leishmaniasis. Clin Exp Dermatol 2000;25:363-70.
13. Pearson RD, Sousa ADQ. Clinical spectrum of leishmaniasis. Clinical Infectious Diseases 1996;22:1- 11.
14. Gürel MS, Yeşilova Y, Ölgen MK, et al. Türkiye’de Kutanöz Leishmaniasisin durumu. Türkiye Parazitol Derg 2012;36:121-9.
15. Wortmann GW, Aronson NE, Miller RS, et al. Cutaneous leishmaniasis following local trauma: a clinical pearl. Clin Infect Dis 2000;31:199-201.
16. Bari A,Rahman SB. Many faces of cutaneous leishmaniasis. Indian J Dermatol Venereol Leprol 2008;74:23-7.
17. Bari AU, Azam S, Ejaz A, et al. Comparison of various cytodiagnostic tests in the rapid diagnosis of cutaneous leishmaniasis. J Pak Assoc Dermatol 2010;20:63-9.
18. Salman SM, Rubeiz NG, Kibbi AG. Cutaneous leishmaniasis: clinical features and diagnosis. Clin Dermatol 1999;17:291-6.
19. Ardehali S, Sodeiphy M, Haghighi P, et al. Studies on chronic (lupoid) leishmaniasis. Ann Trop Med Parasitol 1980;74:439-45.